RG
EBS icon

Renaissance Group’s Emergent Biosolutions EBS Stock Holding History

Renaissance Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,129
Closed -$941K – 283
2021
Q1 		$941K Buy
10,129
+320
+3% +$32.8K 0.04% 174
2020
Q4 		$879K Buy
9,809
+21
+0.2% +$1.93K 0.04% 168
2020
Q3 		$1.01M Sell
9,788
-128
-1% -$13.8K 0.05% 120
2020
Q2 		$784K Buy
+9,916
New +$739K 0.04% 142
2014
Q3 		– Sell
-10,212
Closed -$229K – 268
2014
Q2 		$229K Sell
10,212
-167
-2% -$3.89K 0.01% 260
2014
Q1 		$262K Buy
+10,379
New +$262K 0.01% 184

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Group's EBS Position: Q2 2021 in Review

Renaissance Group sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 10,129 shares — an estimated $941K sold.

Renaissance Group first reported a position in EBS in Q1 2014 and held it in 6 quarters. The position peaked at $1.01M in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Renaissance Group reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Renaissance Group sold 10,129 Emergent Biosolutions shares in Q2 2021, an estimated $941K.
  • Renaissance Group first reported a position in Emergent Biosolutions in Q1 2014 and held it in 6 quarters.
  • Renaissance Group's Emergent Biosolutions position peaked at $1.01M in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Renaissance Group's 13F filing for Q2 2021, filed 13 Aug 2021.